Wall Street Analysts Predict a 28.98% Upside in Harmony Biosciences (HRMY): Here's What You Should Know

Shares of Harmony Biosciences Holdings, Inc. (HRMY) have gained 13.5% over the past four weeks to close the last trading session at $39.54, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$51 indicates a potential upside of 29%.The average comprises 10 short-term price targets ranging from a low of $28 to a high of$75, with a standard deviation of $13.58. While the lowest estim ...